Doctors often fail to recommend or even discuss genetic testing of women at high risk for mutations associated with breast or ovarian cancer, a new study published Tuesday has found.
"Women are very interested in genetic testing but many fail to receive it," said Allison Kurian, a Stanford University Medical School professor and lead author of the study published in JAMA, the Journal of the American Medical Association.
"This is particularly worrisome because it means that doctors are missing the opportunity to prevent cancers in mutation carriers and their family members." Kurian and researchers at the University of Michigan based their findings on a survey of more than 2,500 women with stage 0 to stage 2 cancer two months after surgery.
They were asked if they wanted genetic testing for the presence of mutations in BRCA 1 and BRCA 2 genes and, if so, whether they had received it.
Two thirds of the women said they wanted to be tested, but only a third had received it.
Only 40 percent of all high-risk women reported receiving genetic counseling to help them decide or understand the results.
Comments
Comments are closed for this article.